Navigation Links
OncoSec Medical to Present at the 15th Annual BIO CEO & Investor Conference
Date:2/6/2013

able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy and other treatment alternatives.  OncoSec Medical's core technology is based upon its proprietary use of an electroporation platform to dramatically enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these powerful and targeted anti-cancer agents has demonstrated selective destruction of cancerous cells while sparing healthy normal tissues during early and late stage clinical trials. OncoSec's clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers. More information is available at http://www.oncosec.com/.

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties which may cause our results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include our ability to raise additional funding, our ability to acquire, develop or commercialize new products, uncertainties inherent in pre-clinical studies and clinical trials, unexpected new data, safety and technical issues, competition and market conditions. These and additional risks and uncertainties are more fully described in OncoSec Medical's filings with the Securities and Exchange Commission. Undue reliance should not be placed on forward look
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec Medical to Present at Noble Financial Capital Markets Ninth Annual Equity Conference on January 22
2. OncoSec Medical Announces $7.2 Million Public Offering
3. OncoSec Medical to Present Data at DNA Vaccines 2012 Conference
4. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
5. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
6. OncoSec to Present at Upcoming Healthcare and Investor Conferences
7. OncoSec Granted New Patent from China
8. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
9. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
10. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
11. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... , April 27, 2015  As the Innovation Insight ... Philadelphia , InCrowd, provider of on-demand answers ... of life science insights experts in charting a new ... and innovation in research. Presented jointly by ... by Communispace Health, IIeX Health features TED-style presentations and ...
(Date:4/27/2015)... 2015 - The First Company in ... State Intellectual Property Office of China ... - A New Treatment Which Offers Hope for ... - About 20% of Elderly Urban Chinese Suffer From Peripheral ... Higher Than in Men. CLI is a Progressive Form of ...
(Date:4/26/2015)... , April 26, 2015 Cancer experts ... VAR ) supported project in the area of distributed ... data" for the benefit of patients. Speakers at a ... Society for Therapeutic Radiation Oncology) forum in Barcelona ... treatment and applying that knowledge to help benefit the ...
Breaking Medicine Technology:InCrowd Helps IIeX Health 2015 Chart New Paths for Turning Physician Insights Into Innovation 2InCrowd Helps IIeX Health 2015 Chart New Paths for Turning Physician Insights Into Innovation 3Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 2Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 3Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 4Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 2Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 3
... 17, 2012 SynCardia Systems, Inc. ( www.syncardia.com ), ... Canada and CE (Europe) approved Total Artificial Heart, announced ... due in part to Certified Centers performing a record ... Artificial Heart . (Photo: http://photos.prnewswire.com/prnh/20120517/LA08709 ...
... SAN FRANCISCO, May 17, 2012  Varian Medical Systems (NYSE: ... treating early-stage inoperable lung cancer and other conditions non-invasively ... Society (ATS) later this week in San Francisco.  ... front of pulmonologists who may not be familiar with ...
Cached Medicine Technology:SynCardia Posts Record Revenue and Profit in Q1 2012 2SynCardia Posts Record Revenue and Profit in Q1 2012 3Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer 2Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer 3Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer 4
(Date:4/27/2015)... A' Design Award and Competition is pleased to ... Boombang Inc Design Team has been announced as a ... Instruments, Medical Devices and Research Equipment Design Competition ... Inc Design Team, the creative team behind the awarded ... Lumica is a two-way communication device between patients and ...
(Date:4/27/2015)... On May 15, Mount Soma Ashram students (monks) ... raise awareness of the vision of Mount Soma; the ... Ironically, when many of these people moved to the ... were leaving the social and technological world behind. Ashram ... service to a higher cause, deep introspection, and renunciation ...
(Date:4/27/2015)... April 27, 2015 The global ... a lower CAGR in developed countries; however, it ... countries such as China, India and Brazil in ... analyzers market is driven by factors such as ... laboratories, development of high-throughput hemostasis analyzers, developments in ...
(Date:4/27/2015)... 27, 2015 Healthpointe clinics throughout Southern ... nail fungi and infections. Onychomycosis, which is commonly known ... 10% of adults in the Western population. This fungal ... thickness. , Healthpointe’s Anaheim clinic is home ... dedicated to providing quality skincare products and restorative services. ...
(Date:4/27/2015)... 2015 Scooter Direct is now offering ... discounted price of only $929.00, marked down from the ... store is known for offering quality mobility solutions to ... lifts, wheel chairs, lift chairs, and their accessories at ... features of Go Go Traveller Elite, a senior store ...
Breaking Medicine News(10 mins):Health News:Boombang Inc Design Team wins Platinum in A' Medical Product Design Awards 2Health News:Mount Soma Monks Do Social Media 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 3Health News:Southern California Healthpointe Clinics Now Treating Nail Fungus 2Health News:Scooter Direct Offering Pride Go Go Traveller Elite 3-Wheel Scooter At Discounted Price 2Health News:Scooter Direct Offering Pride Go Go Traveller Elite 3-Wheel Scooter At Discounted Price 3
... , WHITE PLAINS, N.Y., July 14 A new ... - alerting them to a patient,s increased risk for birth defects ... agreement with a $1.2 million grant from the Health Resources and ... The National Coalition for Health Professional Education in Genetics ...
... ... and senior partner at the Pederson Immigration Law Group, P.C. is slated to be ... , ... (PRWEB) July 14, 2009 - The Pederson Immigration Law Group, P.C., (PILG) announced that ...
... , , , ... leading provider of electronic medical records systems, electronic prescribing and advanced ... on June 24(th), 2009. meridianEMR users will now be able to ... in communities throughout all 50 states and Washington, D.C. , ...
... 14, 2009 News media covering chemical sciences, small ... Chemical Society (ACS) Small & Medium Business Webinar on ... and entrepreneurs. Scheduled for Thursday, July ... will feature Kenneth Polk, who joined ACS in October ...
... KANSAS CITY, Mo., July 14 We have all heard this warning: ... Do we first notice the hair, the eyes, or the clothing? ... smile is the first feature we notice about someone. Smiling is also ... we should all be interested in making sure we are taking care of ...
... 14 To help the general public better understand the ... on Skin Cancer Prevention has issued a position statement on ... recommends that vitamin D be obtained from a combination of ... ultraviolet (UV) radiation. , , ...
Cached Medicine News:Health News:New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors' Offices 2Health News:New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors' Offices 3Health News:Pederson Immigration Law Group Attorneys Featured in 14th Annual J-1/H-1B Foreign Physician Immigration Conference and Job Fair Series 2Health News:Pederson Immigration Law Group Attorneys Featured in 14th Annual J-1/H-1B Foreign Physician Immigration Conference and Job Fair Series 3Health News:meridianEMR Completes Surescripts(R) Certification 2Health News:meridianEMR Completes Surescripts(R) Certification 3Health News:Want to attract the opposite sex? It's in the Smile. 2Health News:National Council on Skin Cancer Prevention Encourages Americans to Obtain Vitamin D Through Diet and Supplements 2
... of German Craftsmanship have produced ... the world. Ocutek now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
1mm by 7mm horizontal punch. Flat serrated handle. Overall length 87mm....
... integrated neck. Piston assembly fits into ... spring to recoil back to ready ... into precision milled cavity in platform. ... - 9.0mm. Designed for the preparation ...
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
Medicine Products: